glp-1-receptoragonister GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonist 2 |

Value Health

Onset timeline Most cases of retatrutide skin sensitivity appear within the first 2 to 6 weeks of starting treatment, often coinciding with dose escalation phases

In the AWARD-2 trial (Efficacy and Safety of Once Weekly Dulaglutide vs

[DOI] [PubMed] [Google Scholar] 84.McMorrow HE, Lorch CM, Hayes NW, Fleps SW, Frydman JA, Xia JL, et al

placebo, genital mycotic infections were seen in greater than 10% of women (100mg-10.4%, 300 mg-11.4%, placebo-3.2%) and around 4% of men (100 mg-4.2%, 300 mg-3.7%, placebo- 0.6%) (213)

According to reported trial data, adults taking the 12 mg dose lost an average of 70.3 pounds, equal to about 28.3% of body weight, over 80 weeks